Arthritis Market Research Reports & Industry Analysis
Rheumatoid arthritis (RA) is a systemic inflammatory disease. In the United States, approximately a single percent of the population is affected. Women are two to three times more likely to develop rheumatoid arthritis than men, with peak incidence between the fourth and sixth decades. Gender difference disappears in older age. Rheumatoid arthritis affects all races, and its prevalence is not affected by climate. Eighty percent of rheumatoid arthritis patients test rheumatoid factor (RF) positive.
Arthritis Industry Research & Market Reports
-
Global Osteoarthritis Therapeutics Market 2024-2028
... report on the osteoarthritis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Orthopedic Imaging Equipment Market Size Study & Forecast, By Modality (X-ray, CT, MRI, Ultrasound, Nuclear Imaging), By Indication (Trauma Cases, Sports Injuries, Spinal Injuries, Arthritis, Bone Disorders, Musculoskeletal Cancer, Muscle Atrophy, Others), By End-use (Hospitals, Diagnostic Imaging Centers, Others), and Regional Analysis, 2023-2030
... (Hospitals, Diagnostic Imaging Centers, Others), and Regional Analysis, 2023-2030 Global Orthopedic Imaging Equipment Market is valued at approximately USD 4.68 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Orthobiologics Market Size, Trends, Analysis, and Outlook By Product (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Others), By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft-tissue Injuries, Others), By End-User (Hospitals, Orthopedic Clinics, Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities), by Country, Segment, and Companies, 2024-2032
... Orthopedic Clinics, Ambulatory Care Centers, Research and Academic Institutes, Dental Clinics and Facilities), by Country, Segment, and Companies, 2024-2032 The global Orthobiologics market size is poised to register 5.9% growth from 2024 to 2032, presenting ... Read More
-
Osteoarthritis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029). The COVID-19 pandemic had a short-term impact on the market growth as it led to the cancelation or postponement of the ... Read More
-
Biosimilars Market Size, Trends, Analysis, and Outlook By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Chronic & Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Biosimilars market size is poised to register 12.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilars market across ... Read More
-
Non-Radiographic Axial Spondyloarthritis (nrAxSpA) - Pipeline Insight, 2024
... the Non-Radiographic Axial Spondyloarthritis (nrAxSpA) market. A detailed picture of the Non-Radiographic Axial Spondyloarthritis (nrAxSpA) pipeline landscape is provided, which includes the disease overview and Non-Radiographic Axial Spondyloarthritis (nrAxSpA) treatment guidelines. The assessment part of ... Read More
-
Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Pipeline Insight, 2024
... the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market. A detailed picture of the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) pipeline landscape is provided, which includes the disease overview and Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) treatment guidelines. The assessment part of ... Read More
-
Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Insight, 2024
... growth prospects across the Systemic Juvenile Idiopathic Arthritis (SJIA) market. A detailed picture of the Systemic Juvenile Idiopathic Arthritis (SJIA) pipeline landscape is provided, which includes the disease overview and Systemic Juvenile Idiopathic Arthritis (SJIA) ... Read More
-
Osteoarthritis - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Osteoarthritis Understanding ... Read More
-
Axial Spondyloarthritis - Pipeline Insight, 2024
... picture of the Axial Spondyloarthritis pipeline landscape is provided, which includes the disease overview and Axial Spondyloarthritis treatment guidelines. The assessment part of the report embraces in-depth Axial Spondyloarthritis commercial assessment and clinical assessment of ... Read More
-
Acute Gout Flare - Pipeline Insight, 2024
... Flare market. A detailed picture of the Acute Gout Flare pipeline landscape is provided, which includes the disease overview and Acute Gout Flare treatment guidelines. The assessment part of the report embraces in-depth Acute Gout ... Read More
-
Psoriatic Arthritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Gouty Arthritis (Gout) - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Erosive Hand Osteoarthritis - Pipeline Insight, 2024
... Osteoarthritis market. A detailed picture of the Erosive Hand Osteoarthritis pipeline landscape is provided, which includes the disease overview and Erosive Hand Osteoarthritis treatment guidelines. The assessment part of the report embraces in-depth Erosive Hand ... Read More
-
Knee osteoarthritis – Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024
... the Juvenile Idiopathic arthritis (JIA) market. A detailed picture of the Juvenile Idiopathic arthritis (JIA) pipeline landscape is provided, which includes the disease overview and Juvenile Idiopathic arthritis (JIA) treatment guidelines. The assessment part of ... Read More
-
Polyarticular Juvenile Idiopathic Arthritis - Pipeline Insight, 2024
... the Polyarticular Juvenile Idiopathic Arthritis market. A detailed picture of the Polyarticular Juvenile Idiopathic Arthritis pipeline landscape is provided, which includes the disease overview and Polyarticular Juvenile Idiopathic Arthritis treatment guidelines. The assessment part of ... Read More
-
Axial spondyloarthritis (axSpA) - Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Rheumatoid Arthritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Global Viscosupplementation for Knee Osteoarthritis Market Growth 2024-2030
... in downstream market, the Viscosupplementation for Knee Osteoarthritis is forecast to a readjusted size of US$ 2304 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential ... Read More
-
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Europe, Asia Pacific, Middle East & Africa) Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts ... Read More
-
Global Viscosupplementation Treatment for Arthritis Market Growth 2024-2030
... in downstream market, the Viscosupplementation Treatment for Arthritis is forecast to a readjusted size of US$ 2304 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Porcine Vaccine Market Size, Trends, Analysis, and Outlook By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Disease (Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Circovirus Associated Disease (PCVAD), Others), by Region, Country, Segment, and Companies, 2024-2030 The global Porcine Vaccine market size is poised to register 6.97% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies ... Read More
Research Assistance
